Stem Point Capital LP Applied Therapeutics Inc. Transaction History

Stem Point Capital LP

  • $401 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$4.35 - $8.5 $2.86 Million - $5.58 Million
-656,734 Reduced 29.7%
1,554,586 $13.2 Billion
Q2 2024

Aug 13, 2024
BUY
$4.04 - $6.37 $784,988 - $1.24 Million
194,304 Added 9.63%
2,211,320 $10.3 Billion
Q1 2024

May 13, 2024
BUY
$2.25 - $7.4 $2.5 Million - $8.21 Million
1,109,864 Added 122.35%
2,017,016 $13.7 Billion
Q4 2023

Feb 12, 2024
BUY
$1.84 - $3.35 $1.67 Million - $3.04 Million
907,152 New
907,152 $3.04 Billion

Others Institutions Holding APLT

# of Institutions
131
Shares Held
110M
Call Options Held
1M
Put Options Held
584K
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $29.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email